MedPath

Early Detection of Anaemia During the Maternity

Phase 3
Completed
Conditions
Anemia
Registration Number
NCT00827463
Lead Sponsor
University Hospital, Limoges
Brief Summary

Estimate the efficiency of a strategy of premature screening of the maternal anaemia during the first quarter of pregnancy versus the usual strategy of screening of the anaemia during the sixth month.

Detailed Description

A part of the patient will have a NFS and dosage of the cast-iron, during the results of the beginning of the pregnancy at the first quarter.

The other part of the patients will have a NFS and at the first quater of the pregnancy.

All the patient will have a NFS at the results of the sixth month of the pregnancy.

A NFS will be done during the results at the end of the pregnancy like we do now.

Then a NFS at 48 hours after the birth. A treatment with iron will be done and according to the results

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • Every patient followed at the HME at the beginnig of the pregnancy
Exclusion Criteria
  • pregnency women who don't speak french
  • pregnancy women affected by béta thalassemia
  • pregnancy woman having had a périconceptionnel treatment against the anaemia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
primary outcomes: is the rate of heamophilia at the end of the pregnancy.six months
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes: - the percent of treatment of intravenous irons during the pregnancy and the following layers. - the percent of transfusion and the following layers.6 months

Trial Locations

Locations (1)

CHU limoges

🇫🇷

Limoges, Limousin, France

CHU limoges
🇫🇷Limoges, Limousin, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.